Details
Stereochemistry | ACHIRAL |
Molecular Formula | C8H8O2 |
Molecular Weight | 136.1479 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=O)OC1=CC=CC=C1
InChI
InChIKey=IPBVNPXQWQGGJP-UHFFFAOYSA-N
InChI=1S/C8H8O2/c1-7(9)10-8-5-3-2-4-6-8/h2-6H,1H3
Phenylacetate is the ester of a phenol and acetic acid. It is a metabolite of anticancer drug phenylbutyrate (PB), natural neurotransmitter phenylethylamine. Naturally, it is an odorant found in strawberries, passion fruit, and black tea. Phenylacetate level in urine was used as a marker for the diagnosis of some forms of unipolar major depressive disorders. Phenylacetate is used as a tool substrate to study esterase activity in the blood of patients in clinical studies of the effect of nutritional supplements on paraoxonase-1 levels.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL3167 Sources: https://www.ncbi.nlm.nih.gov/pubmed/12729627 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Diagnostic | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Comparison of the gravimetric, phenol red, and 14C-PEG-3350 methods to determine water absorption in the rat single-pass intestinal perfusion model. | 2001 |
|
An exploratory analysis of the effect of pesticide exposure on the risk of spontaneous abortion in an Ontario farm population. | 2001 Aug |
|
High-density lipoprotein composition and paraoxonase activity in Type I diabetes. | 2001 Dec |
|
Suppression of depleted uranium-induced neoplastic transformation of human cells by the phenyl fatty acid, phenyl acetate: chemoprevention by targeting the p21RAS protein pathway. | 2001 Jan |
|
Olfactory discrimination ability for aromatic odorants as a function of oxygen moiety. | 2002 Jan |
|
Heteropoly acid as a novel efficient catalyst for Fries rearrangement. | 2002 Jun 7 |
|
The ratio of serum paraoxonase/arylesterase activity using an improved assay for arylesterase activity to discriminate PON1(R192) from PON1(Q192). | 2003 |
|
Preferential inhibition of paraoxonase activity of human paraoxonase 1 by negatively charged lipids. | 2004 Dec |
|
Thermodynamically controlled synthesis of amide bonds catalyzed by highly organic solvent-resistant penicillin acylase derivatives. | 2004 Jan-Feb |
|
Enantioselective synthesis of phenylacetamides in the presence of high organic cosolvent concentrations catalyzed by stabilized penicillin G acylase. Effect of the acyl donor. | 2004 May-Jun |
|
Acetoclastic and hydrogenotrophic methane production and methanogenic populations in an acidic West-Siberian peat bog. | 2004 Nov |
|
Serum arylesterase and paraoxonase activity in patients with chronic hepatitis. | 2005 Dec 14 |
|
Ab initio study of the substituent effects on the relative stability of the E and Z conformers of phenyl esters. Stereoelectronic effects on the reactivity of the carbonyl group. | 2005 Jul 21 |
|
High yield recombinant penicillin G amidase production and export into the growth medium using Bacillus megaterium. | 2006 Nov 28 |
|
Synthesis and evaluation of phenoxy acetic acid derivatives as [corrected] anti-mycobacterial agents. | 2006 Sep 1 |
|
Topical ocular delivery of NSAIDs. | 2008 Jun |
|
Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells. | 2008 Oct 16 |
|
Effect of 7Li radiation on endogenous hormonal level on developing cotton fiber. | 2008 Sep |
|
Total synthesis of psoralidin, an anticancer natural product. | 2009 Apr 3 |
|
Determinants of variation in human serum paraoxonase activity. | 2009 Feb |
|
Synthesis and evaluation of in vitro antiviral activity of novel phenoxy acetic acid derivatives. | 2009 Jun |
|
Paraoxonase 1 activity in different types of multiple sclerosis. | 2009 Mar |
|
High prevalence of low serum paraoxonase-1 in subjects with coronary artery disease. | 2009 Nov |
|
Dramatic differences in organophosphorus hydrolase activity between human and chimeric recombinant mammalian paraoxonase-1 enzymes. | 2009 Nov 3 |
|
Effect of loading rate and HRT on the removal of cephalosporin and their intermediates during the operation of a membrane bioreactor treating pharmaceutical wastewater. | 2009 Sep |
|
Chemical and enzymatic stability of amino acid prodrugs containing methoxy, ethoxy and propylene glycol linkers. | 2009 Sep-Oct |
|
Synthesis of cholesterol-conjugated magnetic nanoparticles for purification of human paraoxonase 1. | 2010 Oct |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15576850
Arylesterase activity was measured as the rate of hydrolysis of phenylacetate into phenol. This process can be detected spectrophotometrically. Serum samples were prepared in sample buffer consisting of 20 mM Tris and 0.9 mM CaCl2 (pH 8.0) in a 40-fold dilution. Five ul of diluted serum was then added to 200 ul of freshly made substrate buffer containing 1 mM phenylacetate, 20 mM Tris, and 0.9 mM CaCl2. The reaction was monitored on a microtiter plate at 260 nm in a Fluostar microplate reader at 37°C. The nonenzymatic hydrolysis of phenylacetate, based on the hydrolysis rate in the absence of serum, was subtracted from the total rate of hydrolysis.
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
77993
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
||
|
FDA ORPHAN DRUG |
110698
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
||
|
NCI_THESAURUS |
C1934
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
||
|
FDA ORPHAN DRUG |
11385
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
||
|
LOINC |
75062-0
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
||
|
JECFA EVALUATION |
PHENYL ACETATE
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
122-79-2
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
PRIMARY | |||
|
70619
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
PRIMARY | RxNorm | ||
|
DTXSID3051626
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
PRIMARY | |||
|
8082
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
PRIMARY | |||
|
204-575-0
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
PRIMARY | |||
|
m8649
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
PRIMARY | Merck Index | ||
|
C1501
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
PRIMARY | |||
|
605
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
PRIMARY | |||
|
SUB181406
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
PRIMARY | |||
|
PHENYL ACETATE
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
PRIMARY | |||
|
2667
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
PRIMARY | |||
|
31229
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
PRIMARY | |||
|
27795
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
PRIMARY | |||
|
18401
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
PRIMARY | |||
|
355G9R500Y
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
PRIMARY | |||
|
100000167072
Created by
admin on Fri Dec 15 15:04:28 GMT 2023 , Edited by admin on Fri Dec 15 15:04:28 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD